A talk I gave at OSCON Data 2011 on how personalized medicine, data analysis, and open source synthetic biology can work together.
1 of 41
Downloaded 39 times
More Related Content
Synthetic Biology and Data-Driven Synthetic Biology for Personalized Medicine and Clean Energy at O\'Reilly\'s OSCON Data in Portland, OR
1. SYNTHETIC BIOLOGY AND
DATA-DRIVEN SYNTHETIC
D
BIOLOGY FOR PERSONALIZED
MEDICINE AND CLEAN
ENERGY
Russell Hanson
OSCON D t J l 25 27 2011
Data July 25-27,
Portland, OR
Russell Hanson
Dec 27, 2004 TheCureIsNow.org
2. Outline
What is synthetic biology?
y gy
How does synthetic biology relate to genomic
science/personalized medicine
Open source tools in science and
bioengineering/synbio
Bio-Computer aided design (AutoCAD, etc.)
Mesoscopic Physics
p y
Diff Eqs and parameter optimizations
OSCON Data Portland, OR
3. Outline, cont.
IP Issues in personalized medicine
Pink Army and co-op, open-source biopharma
Non-profit clinical research organizations
Non profit
(CROs)
Disease-management companies, broken
Disease management
business model
Big Data in electronic medical records,
personal genomics, biostatistics, hospitals,
community health centers
OSCON Data Portland, OR
4. OSCON Data: This may not be a talk
about a social web app and the
pp
database technologies used for that
app, but truly, what would a social web,
pp, y, ,
etc. app be without the life or biology
on that social graph
g p
OSCON Data Portland, OR
5. What is life?
What is artificial life?
And, incidentally, what is consciousness?
Igor Aleksander (1995) Bernard Baars (1988)
Brain as state machine Definition and context setting
Inner neuron partitioning Adaptation and learning
Conscious and unconscious states Editing
Perceptual learning and memory Flagging and debugging
Prediction Recruiting and control
Self-Awareness Decision-making (executive function)
Representation and meaning Analogy forming-function
Learning utterances Metacognitive and self monitoring
self-monitoring
Learning language function
Will Autoprogramming and self-maintenance
Instinct function
Emotion Definitional and context-setting
context setting
function
OSCON Data Portland, OR
from When The Turing Test Is Not Enough, by George Dvorsky
6. We are open source
Life is open source
We should have excellent tools
to manage our source (code)
OSCON Data Portland, OR
12. Single nucleotide polymorphism
(SNP) and gene expression arrays
CCopy number profile
b fil
Gene expression/over expression levels in
a tissue
Major copy proportion
j py p p
Machine learning on SNPs, SVM, Bayesian
networks, Markov chains
Biomarker identification, verification, and
development.
development Biomarker for autism lack
autism, lack
of empathy OSCON Data Portland, OR
13. Where are we?
How much do we know about cellular
processes, regulation, oncogenes,
l ti
protein-protein interactions, microbiome
interactions?
i t ti ?
How much do we know about brain
structure-function relationships, gene
activation in neurons, memory,
eletrophysiology, neuronal cognition,
brainmaps from C. elegans, to Mus
musculus, to Homo sapiens?
OSCON Data Portland, OR
14. How to Access the Human Genome (and other
seque ced genomes)
sequenced ge o es)
ftp://ftp.ncbi.nih.gov
hs_phs0.fna.gz Survey sequence (appr
hs_phs1.fna.gz Unordered contigs (ea
hs_phs2.fna.gz Ordered contigs (each
hs_phs3.fna.gz Finished sequence
21C3 Berlin
15. The second wave of synthetic
biology: from modules to systems
systems
The second wave of synthetic biology: from
y gy
modules to systems, Purnick PEM, Weiss R,
Nature Reviews Molecular Cell Biology, Vol 10 OSCON Data Portland, OR
Iss 6 P410-422 Jun 2009
16. Using increasing abstraction, performance
characteristics, datasheets -- like
integrated circuits (ICs)
OSCON Data Portland, OR
19. Nanobots to treat NK leukemia cells
DNA scaffolds and
cell-surface receptors
Software, etc. for DNA
origami, scaffold design
OSCON Data Portland OR
20. 23andMe, NextGen sequencing and
SynBio get together
23andMe version 3 uses
Illumina
HumanOmniExpress
BeadChip SNP chips
($250/sample)
Genome Wide Association
Studies
--> At $250/sample,
genomic personalization is
very realizable OSCON DATA Portland, OR
21. More new CAD/BioCAD software tools
Matter compiler
Thingiverse, cheap 3d printers, laser
g , p p ,
cutters, Shapeways, personal fab
technology, makerbot, etc.
gy, ,
AutoDesk, EugeneCAD,
ClothoCAD
RepRap exponentially
scalable matter compiler
/
/extruding 3D p
g printer
OSCON Data Portland, OR
22. Movie at:
p // /
http://www.molecularmovies.com/movi
es/berry_apoptosis.html
Apoptosis Maya Animation by Drew Berry OSCON Data Portland, OR
23. Biological simulators
simulators
NAMD and other molecular dynamics, etc.
Mixed Quantum Mechanics/Molecular
Mechanics (QM/MM/)
(QM/MM/ )
Biological pathway/chemical reaction
simulators/optimizers
Many projects on gene network analysis,
stochastic simulation, etc.
h i i l i
OSCON Data Portland, OR
24. Design of bio/chemical devices from
(1) first principles and functional
fi t i i l df ti l
abstractions and (2) from data
Data
Bio/chem/phys first principles
and functional abstractions
OSCON DATA Portland, OR
25. How and where these data are
used,
used or made usable
Randomized clinical trials
Biomarker development, genomic tests
in CLIA certified labs
Licensing to other companies for
marketing and development
OSCON Data Portland, OR
26. Tools that are used to analyze
these data
R (!), BioConductor
Biostatistics, Matlab
Python
Chi-square tests,
permutation tests, Monte Carlo resampling
Parametric statistics, nonparametric
statistics, generative statistics
Statistical learning theory, online learning
theory
OSCON Data Portland, OR
27. Approval of processes for
cellular therapies/treatments
FDA approval for process, not f
lf t for
drug/biologic/device
progress on the development of a new experimental MCL treatment called
immunotherapy, in which a patients own immune cells are collected from the
bloodstream before ASCT, treated in the laboratory to have antitumor activity,
and reintroduced into the body after ASCT. The goal of this immunotherapy is
to reduce the likelihood of relapse after transplantation. A major challenge of
immunotherapy is getting the transferred immune cells to persist in the body
after the transfer. In preclinical studies, Dr. Jensen and his colleagues found
ft th t f I li i l t di D J d hi ll f d
that using a certain subset of immune cells called central memory T-cells in-
creased the likelihood that the transferred T-cells will persist.
Report from the Lymphoma Research Foundation, Spring 2010, Volume 8,
Number 1 OSCON Data Portland, OR
28. Pink Army a
biopharma co-op
bi h
You own your own cells, therapies based off your
own cells should be yours in the co-op.
If a biopharma company cures your disease, they
lose a customer, who is cured.
2 weeks and
$1000 in lab resources
OSCON Data Portland OR
29. Cancer 5-year survival rates, US
OSCON Data Portland, OR
Division of Cancer Control and Population Sciences, 2008
30. Non-profit clinical research
organizations ( (CROs)
)
Randomized trials
A melanoma trial with 1,000 patients
1 000
costs $60M in CRO expenses
A 10,000 patient chronic obstructive
10 000
pulmonary disease (COPD) costs $240-
$250M in CRO expenses
OSCON Data Portland, OR
31. More medical foci of SynBio
y
Oncolytic viruses
y
RNAi for HER2 in breast cancer (also an
iGEM team project)
Designed, logic, and programmed
Not comp tational devices b t use logic
computational de ices but se
and/or procedures
OSCON Data Portland OR
32. Using data to engineer therapies
or cures for genetic diseases
IF ( RNA AND RNA AND RNA AND RNA AND RNA )
THEN
RELEASE PROTEIN INITIATING APOPTOSIS IN THE TUMOR CELL
OSCON Data Portland OR
33. More biological nanobots
T t h d l robots, made from biological or organic
Tetrahedral b t d f bi l i l i
substrate: 12Tet Tetrahedral Rover Robot
http://www.youtube.com/watch?v txZMLS7YD6Q
http://www.youtube.com/watch?v=txZMLS7YD6Q
OSCON Data Portland, OR
35. Energy, biofules
Energy biofules, and bioreactors
The oil multinational, despised by green activists for its support of
, p yg f pp f
scientists skeptical of climate change, plans to invest $600 million (贈370
million) in a joint venture with Mr Venters company, Synthetic Genomics. The
thinking is that algae is a more efficient source of fuel than conventional
biofuels, such as ethanol made from corn or sugar cane and biodiesel made
from wheat or palm oil. Algae can be processed into fuels similar to petrol
and diesel and it consumes carbon dioxide as it grows.
According to Exxon, the yield of biofuel from algae is 2,000 gallons per
A di E h i ld f bi f l f l i 2 000 ll
acre, more than three times that of biodiesel from palm oil and eight times the
ethanol yield from corn. It is also believed to have the edge over other
biofuels because of its suitability for use as a jet fuel. The real challenge to
fuel The
creating a viable, next-generation biofuel is the ability to produce it in large
volumes, Mr Venter said.
via http://www.timesonline.co.uk/tol/news/environment/article6710846.ece
OSCON Data Portland OR
39. Microbiome Engineering
Use the microbiome to produce therapies
for existing diseases in controlled,
continuous ways: insulin for diabetics,
interleukin 10 for Crohns disease, etc.
Highly competitive environment: microbe
needs orthogonal edge to survive
g g
OSCON Data Portland, OR
40. And so forth and biology
PolySilicon and biology
SynBio in chemicals industry cleaning
cleaning,
refinement, scalability, sensors, etc.
OSCON Data Portland, OR
41. Conclusions
Wide ranging implications to existing problems in
health, engineering, energy, manufacture
P ti l l for human healthcare, genomic research
Particularly f h h lth i h
on diseases, data-aided design and testing
New manufacture processes for new biologically-
biologically
designed constructs
http://www.linkedin.com/in/russellhanson
http://twitter.com/russell_hanson
http://www.russellhanson.com/
http://www russellhanson com/
OSCON Data Portland OR